Profound Medical Corp. Financials

Market Capitalization C$244.9 Million as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE
Forward PE	-15.17
Price to Sales TTM	C$33.97
Price to Book MRQ	C$6.86
Enterprise to Revenue	31.43
Enterprise to EBITDA	-8.12

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	60.87%
Operating Margin	-437.13%
Return on Assets TTM	-33.02%
Return on Equity TTM	-68.69%

Income Statement

Revenue TTM	C$9,836,713
Revenue per Share TTM	C$0.34
Quarterly Revenue Growth	59.80%
Gross Profit TTM	C$4,382,000
EBITDA	C$-38,078,835
Net Income to Common TTM	C$-39,036,681
Diluted EPS TTM	C$-1.86
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	C$35,817,443
Total Cash per Share MRQ	C$1.07
Total Debt MRQ	C$
Total Debt to Equity MRQ	25.47
Current Ratio MRQ	6.58
Book Value per Share MRQ	C$1.46

Cash Flow

Operating Cash Flow TTM	C$-30,466,620
Levered Free Cash Flow TTM	C$-18,308,735

PRN Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	24,428,900
Float Shares	22,211,732
Avg 10 Volume	4,630
Avg 30 Volume	None
Shares Short	82,323
Short Ratio	19.55
Short % of Shares	%
% Held by Insiders	8.71%
% Held by Institutions	40.85%

Stock Price Summary

Beta	0.79
Fifty Two Week Low	C$9.55
Fifty Two Week High	C$20.44
Fifty Two Week Change	-81.51%
Day 50 MA	C$11.17
Day 200 MA	C$12.20

Dividends and Splits

Forward Annual Dividend Rate	C$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	C$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2019-10-16
Ex Dividend Date
Last Split Factor
Last Split Date	2019-10-16